Impact Factor 3.634 | CiteScore 3.51
More on impact ›

Perspective ARTICLE Provisionally accepted The full-text will be published soon. Notify me

Front. Endocrinol. | doi: 10.3389/fendo.2019.00814

The POSEIDON criteria and its measure of success through the eyes of clinicians and embryologists

  • 1Androfert, Andrology and Human Reproduction Clinic, Brazil
  • 2University of Naples Federico II, Italy
  • 3Aarhus University, Denmark
  • 4Fertility Center Hamburg (FCH), Germany
  • 5Laboratory of Reproductive Biology, Rigshospitalet, Denmark
  • 6Independent researcher, Germany
  • 7Department of Women's and Children's Health, Faculty of Life Sciences & Medicine, King's College London, United Kingdom
  • 8Department of Reproductive Medicine, Dexeus University Hospital, Spain
  • 9Instituto Valenciano de Infertilidad (IVI), Italy
  • 10Service de Médecine de la Reproduction et Préservation de la Fertilité, Hôpital Antoine-Béclère, France
  • 11Anatolia IVF Center, Turkey
  • 12Clínica Origen, Brazil
  • 13Independent researcher, Vietnam
  • 14Nova IVI Fertility, India
  • 15GENERA reparto di PMA della Clinica Valle Giulia, Italy

This article represents a perspective viewpoint on the POSEIDON criteria by a group of clinicians and embryologists. Its primary objective is to serve as a perspective summary for the relevant Frontiers research topic “POSEIDON’s Stratification of ‘Low Prognosis Patients in ART”. ‘Low prognosis’ relates with reduced oocyte number, which can be associated with low or sometimes a normal ovarian reserve and is aggravated by advanced female age. These aspects will ultimately affect the number of embryos generated and consequently, the cumulative live birth rate. The novel system relies on female age, ovarian reserve markers, ovarian sensitivity to exogenous gonadotropin, and the number of oocytes retrieved, which will both identify the patients with low prognosis and stratify such patients into one of four groups of women with “expected” or “unexpected” impaired ovarian response to appropriate exogenous gonadotropin stimulation. Furthermore, the POSEIDON group introduced a new measure of clinical success in ART, namely, the number of oocytes needed to obtain at least one euploid blastocyst for transfer in each patient. Using the POSEIDON criteria, the clinician would firstly identify and classify patients who have low prognosis in ART, and secondly, aim at designing an individualized treatment plan to maximize the chances of achieving the POSEIDON measure of success in each of the four low prognosis groups. The novel POSEIDON classification system is anticipated to improve counseling and management of low prognosis patients undergoing ART, with an expected positive effect on reproductive success and a reduction in time to live birth.

Keywords: POSEIDON criteria, ovarian stimulation, low prognosis, hypo-responder, oocyte, Blastocyst, Assisted Reproductive Technology, ART calculator, perspective, Poor ovarian response

Received: 08 Jun 2019; Accepted: 06 Nov 2019.

Copyright: © 2019 Esteves, Alviggi, Humaidan, Fischer, Andersen, Conforti, Bühler, Sunkara, Polyzos, Galliano, Grynberg, Yarali, Özbek, Roque, Vuong, Banker, Rienzi, Vaiarelli, Cimadomo and Ubaldi. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence:
Mx. Sandro C. Esteves, Androfert, Andrology and Human Reproduction Clinic, Campinas, Brazil, s.esteves@androfert.com.br
Mx. Peter Humaidan, Aarhus University, Aarhus, 8000, Central Denmark Region, Denmark, peter.humaidan@midt.rm.dk